Carrera Capital Advisors acquired a new position in shares of The Clorox Company (NYSE:CLX – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 17,570 shares of the company’s stock, valued at approximately $2,854,000.
Several other institutional investors have also added to or reduced their stakes in CLX. Catalyst Capital Advisors LLC acquired a new stake in Clorox in the 3rd quarter valued at approximately $54,000. Los Angeles Capital Management LLC raised its holdings in shares of Clorox by 5.6% in the third quarter. Los Angeles Capital Management LLC now owns 191,919 shares of the company’s stock valued at $31,266,000 after purchasing an additional 10,149 shares during the last quarter. Advisors Asset Management Inc. lifted its position in shares of Clorox by 43.4% in the third quarter. Advisors Asset Management Inc. now owns 29,865 shares of the company’s stock worth $4,865,000 after purchasing an additional 9,037 shares in the last quarter. Natixis Advisors LLC boosted its holdings in Clorox by 8.3% during the third quarter. Natixis Advisors LLC now owns 63,476 shares of the company’s stock worth $10,341,000 after purchasing an additional 4,839 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its position in Clorox by 1.8% in the third quarter. Charles Schwab Investment Management Inc. now owns 723,906 shares of the company’s stock valued at $117,932,000 after purchasing an additional 13,038 shares in the last quarter. 78.53% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of equities analysts have recently commented on CLX shares. JPMorgan Chase & Co. increased their price objective on shares of Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 4th. Wells Fargo & Company increased their price target on Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a research report on Tuesday, February 4th. Barclays boosted their price target on Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a research report on Wednesday, February 5th. StockNews.com downgraded Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. Finally, DA Davidson lowered their target price on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a report on Wednesday, February 5th. Three analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $159.62.
Clorox Trading Down 3.3 %
Shares of CLX stock opened at $150.77 on Wednesday. The stock has a 50 day simple moving average of $156.48 and a 200 day simple moving average of $160.48. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.37. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The stock has a market cap of $18.57 billion, a P/E ratio of 41.19, a price-to-earnings-growth ratio of 2.62 and a beta of 0.42.
Clorox (NYSE:CLX – Get Free Report) last issued its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating analysts’ consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period in the prior year, the firm posted $2.16 EPS. On average, research analysts predict that The Clorox Company will post 7.15 earnings per share for the current fiscal year.
Clorox Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd will be paid a dividend of $1.22 per share. The ex-dividend date is Wednesday, April 23rd. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.24%. Clorox’s payout ratio is presently 133.33%.
About Clorox
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Recommended Stories
- Five stocks we like better than Clorox
- How Investors Can Find the Best Cheap Dividend Stocks
- GitLab: Get In While It’s Down—Big Rebound Ahead
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Tesla Stock: Finding a Bottom May Take Time
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Duolingo: This Beaten-Down Stock Is About to Rally 38%
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.